Tech
US health regulator approves anti-anxiety device from Belfast-based Neurovalens
Healthtech firm received FDA clearance in October for an anti-insomnia device and has approvals pending for the treatment of PTSD and obesity
Neurovalens, the Belfast-based healthtech startup, has received approval from the US Food & Drug Administration (FDA) for an electrical stimulation anti-anxiety device.
The firm’s Modius Stress device, designed to treat anxiety by delivering a small electrical pulse to the head for 30 minutes at night, can now be sold directly to sufferers of General Anxiety Disorder (GAD) in the United States who hold a prescription from a doctor.
Neurovalens announced that it had closed a ...